In-utero exposure to tenofovir is associated with impaired fetal and infant growth: need for follow-up studies in combination antiretroviral therapy/HIV-exposed infants: author's reply

Autor:	Madeleine Bunders, Mieke H. Godfried, Taco W. Kuijpers, Henriette J. Scherpbier, A. van de Plas, Colette Smit, Dasja Pajkrt, Jeannine F. J. B. Nellen, E. van Leeuwen, Sophie Cohen, Annouschka M Weijsenfeld, Lisanne Denneman
Přispěvatelé:	General Internal Medicine, AII - Infectious diseases, Amsterdam institute for Infection and Immunity, Amsterdam Reproduction & Development (AR&D), Other Research, Infectious diseases, Paediatric Infectious Diseases / Rheumatology / Immunology, Other departments, Experimental Immunology, Amsterdam Gastroenterology Endocrinology Metabolism, MUMC+: DA KFT Medische Staf (9), RS: FHML non-thematic output
Rok vydání:	2017
Předmět:	0301 basic medicine Pediatrics medicine.medical_specialty Tenofovir Anti-HIV Agents Immunology Human immunodeficiency virus (HIV) MEDLINE HIV Infections medicine.disease_cause 03 medical and health sciences 0302 clinical medicine medicine Immunology and Allergy Humans 030212 general & internal medicine Pregnancy Complications Infectious Fetus OUTCOMES Infectious disease transmission business.industry Follow up studies Infant 030112 virology Antiretroviral therapy Infectious Disease Transmission Vertical Infectious Diseases PREGNANCY In utero SAFETY business medicine.drug Follow-Up Studies
Zdroj:	AIDS (London, England), 31(4), 596-598. Lippincott Williams and Wilkins Aids, 31(4), 596-598. LIPPINCOTT WILLIAMS & WILKINS
ISSN:	1473-5571 0269-9370
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45af4a84fcc35986712a8dd0c568535b https://pubmed.ncbi.nlm.nih.gov/28118235 Zobrazit plný text záznamu